Effects of Low Dose Neuromuscular Blocker Usage on Laryngeal Mask Application
Comparison of Effects of Low Dose Neuromuscular Blocker Added to Propofol Fentanyl Combination During Lma Procedures in Cystoscopy Patients
1 other identifier
interventional
96
1 country
1
Brief Summary
Cystoscopy is a simple, effective and reliable method in current urological practice. Anesthesia may be required in cystoscopy for therapeutic purpose, however it may not be necessary for diagnostic cystoscopy. General anesthesia, spinal anesthesia, epidural anaesthesia and senile block methods may be performed in therapeutic cystoscopy. Pain is main reason of failed cystoscopy. Sedo-analgesia and LMA are generally used for diagnostic cystoscopies. LMA is mostly placed under general anesthesia with the combination of propofol-fentanyl and volatile anesthetics. There is no need for muscle relaxant administration in LMA placement, as it is necessary for intubation. However if muscle relaxant is not used, side effects like hiccup, straining, cough, undesirable muscle movement, hypoxia and laryngeal spasm may be observed. For the improvement of the patient comfort the use of effective muscle relaxants are described in several studies in literature. This study aimed to reveal the quality of anesthesia, hemodynamics, surgical comfort, extra propofol need and recovery time while low dose of muscle relaxant rocuronium was added to propofol-fentanyl combination for LMA placement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2017
CompletedFirst Submitted
Initial submission to the registry
November 15, 2017
CompletedFirst Posted
Study publicly available on registry
February 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2018
CompletedJune 13, 2018
June 1, 2018
1.9 years
November 15, 2017
June 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
questionnaire
The quality of LMA placement with or without neuromusculer drug.
up to first 60 minutes
Secondary Outcomes (1)
questionnaire
up to first 24 hours
Study Arms (2)
lma with rocuronium bromide
EXPERIMENTALIn study group, 2-3 mg/kg propofol, 1mcg/kg fentanyl and 0.15 mg/kg rocuronium bromide will be administered during lma insertion in cystoscopy procedure.
lma with saline solution
ACTIVE COMPARATORIn control group, 2-3 mg/kg propofol, 1 mcg/kg fentanyl and saline(no rocuronium) will be administered during lma insertion in cystoscopy procedure.
Interventions
0.15 mg/kg rocuronium bromide
1mcg/kg for induction
2-3mg/kg for anaesthetic induction
patients will treated with this surgical procedure
Eligibility Criteria
You may qualify if:
- Male patients
- ASA I-II patients
- Cystoscopy patients
- patients entubated with lariyngeal mask
You may not qualify if:
- Female patients
- Asa III-IV patients
- Surgery duration is more than 2 hours
- Drug abusers
- Non compromising patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erciyes University
Kayseri, 38039, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
ayşe ülgey, md
TC Erciyes University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor
Study Record Dates
First Submitted
November 15, 2017
First Posted
February 7, 2018
Study Start
January 4, 2017
Primary Completion
December 4, 2018
Study Completion
December 10, 2018
Last Updated
June 13, 2018
Record last verified: 2018-06